Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses

Differential diagnosis: imaging to tell the difference Brain imaging could be used to distinguish between patients with corticobasal degeneration (CBD) and Parkinson's disease (PD). CBD is a rare condition caused by the gradual loss of brain cells in areas of the brain that link thinking to mov...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Franziska Albrecht, Sandrine Bisenius, Rodrigo Morales Schaack, Jane Neumann, Matthias L. Schroeter
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/3dc9ce18e36a4930aa2c9587c7f870cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3dc9ce18e36a4930aa2c9587c7f870cd
record_format dspace
spelling oai:doaj.org-article:3dc9ce18e36a4930aa2c9587c7f870cd2021-12-02T11:42:13ZDisentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses10.1038/s41531-017-0012-62373-8057https://doaj.org/article/3dc9ce18e36a4930aa2c9587c7f870cd2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41531-017-0012-6https://doaj.org/toc/2373-8057Differential diagnosis: imaging to tell the difference Brain imaging could be used to distinguish between patients with corticobasal degeneration (CBD) and Parkinson's disease (PD). CBD is a rare condition caused by the gradual loss of brain cells in areas of the brain that link thinking to movement. The clinical features of CBD, referred to as corticobasal syndrome (CBS), are similar to those of patients with PD, but they progress differently. To aid earlier and more accurate diagnosis, Franziska Albrecht, at the Max Planck Institute for Human Cognitive and Brain Sciences, Germany, and colleagues reviewed 11 magnetic resonance imaging studies to find brain areas that are specifically affected in CBS/CBD patients. They show that cell loss in specific regions of the motor areas and frontomedian cortex is a hallmark of CBS/CBD, whereas cell loss in the thalamus and parts of the frontal/precentral gyrus were associated with other neurodegenerative diseases.Franziska AlbrechtSandrine BiseniusRodrigo Morales SchaackJane NeumannMatthias L. SchroeterNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 3, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Franziska Albrecht
Sandrine Bisenius
Rodrigo Morales Schaack
Jane Neumann
Matthias L. Schroeter
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
description Differential diagnosis: imaging to tell the difference Brain imaging could be used to distinguish between patients with corticobasal degeneration (CBD) and Parkinson's disease (PD). CBD is a rare condition caused by the gradual loss of brain cells in areas of the brain that link thinking to movement. The clinical features of CBD, referred to as corticobasal syndrome (CBS), are similar to those of patients with PD, but they progress differently. To aid earlier and more accurate diagnosis, Franziska Albrecht, at the Max Planck Institute for Human Cognitive and Brain Sciences, Germany, and colleagues reviewed 11 magnetic resonance imaging studies to find brain areas that are specifically affected in CBS/CBD patients. They show that cell loss in specific regions of the motor areas and frontomedian cortex is a hallmark of CBS/CBD, whereas cell loss in the thalamus and parts of the frontal/precentral gyrus were associated with other neurodegenerative diseases.
format article
author Franziska Albrecht
Sandrine Bisenius
Rodrigo Morales Schaack
Jane Neumann
Matthias L. Schroeter
author_facet Franziska Albrecht
Sandrine Bisenius
Rodrigo Morales Schaack
Jane Neumann
Matthias L. Schroeter
author_sort Franziska Albrecht
title Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
title_short Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
title_full Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
title_fullStr Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
title_full_unstemmed Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
title_sort disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ale meta-analyses
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3dc9ce18e36a4930aa2c9587c7f870cd
work_keys_str_mv AT franziskaalbrecht disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses
AT sandrinebisenius disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses
AT rodrigomoralesschaack disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses
AT janeneumann disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses
AT matthiaslschroeter disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses
_version_ 1718395335802355712